BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29861427)

  • 1. Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors.
    Hoffmann MJ; Dehn J; Droop J; Niegisch G; Niedworok C; Szarvas T; Schulz WA
    Noncoding RNA; 2015 Dec; 1(3):266-284. PubMed ID: 29861427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.
    Kotake Y; Nakagawa T; Kitagawa K; Suzuki S; Liu N; Kitagawa M; Xiong Y
    Oncogene; 2011 Apr; 30(16):1956-62. PubMed ID: 21151178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
    Aguilo F; Zhou MM; Walsh MJ
    Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li Z; Qiao J; Ma W; Zhou J; Gu L; Deng D; Zhang B
    Front Cell Dev Biol; 2022; 10():993525. PubMed ID: 36176277
    [No Abstract]   [Full Text] [Related]  

  • 5. Circular
    Muniz L; Lazorthes S; Delmas M; Ouvrard J; Aguirrebengoa M; Trouche D; Nicolas E
    RNA Biol; 2021 Mar; 18(3):404-420. PubMed ID: 32862732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
    Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
    PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Positive Correlations between
    Drak Alsibai K; Vacher S; Meseure D; Nicolas A; Lae M; Schnitzler A; Chemlali W; Cros J; Longchampt E; Cacheux W; Pignot G; Callens C; Pasmant E; Allory Y; Bieche I
    Noncoding RNA; 2019 Aug; 5(3):. PubMed ID: 31438464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma.
    Chen D; Zhang Z; Mao C; Zhou Y; Yu L; Yin Y; Wu S; Mou X; Zhu Y
    Cell Immunol; 2014; 289(1-2):91-6. PubMed ID: 24747824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
    Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
    Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
    Zhuang J; Peng W; Li H; Wang W; Wei Y; Li W; Xu Y
    PLoS One; 2012; 7(10):e47193. PubMed ID: 23091611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16 (INK4a) Expression.
    Royds JA; Pilbrow AP; Ahn A; Morrin HR; Frampton C; Russell IA; Moravec CS; Sweet WE; Tang WH; Currie MJ; Hung NA; Slatter TL
    Front Oncol; 2015; 5():306. PubMed ID: 26835415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.
    Gonzalez S; Klatt P; Delgado S; Conde E; Lopez-Rios F; Sanchez-Cespedes M; Mendez J; Antequera F; Serrano M
    Nature; 2006 Mar; 440(7084):702-6. PubMed ID: 16572177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.
    Yap KL; Li S; Muñoz-Cabello AM; Raguz S; Zeng L; Mujtaba S; Gil J; Walsh MJ; Zhou MM
    Mol Cell; 2010 Jun; 38(5):662-74. PubMed ID: 20541999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.
    Faderl S; Kantarjian HM; Estey E; Manshouri T; Chan CY; Rahman Elsaied A; Kornblau SM; Cortes J; Thomas DA; Pierce S; Keating MJ; Estrov Z; Albitar M
    Cancer; 2000 Nov; 89(9):1976-82. PubMed ID: 11064355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture.
    Naemura M; Tsunoda T; Inoue Y; Okamoto H; Shirasawa S; Kotake Y
    Mol Cell Biochem; 2016 Jan; 412(1-2):141-6. PubMed ID: 26708220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer.
    Bahrami A; Hassanian SM; Khazaei M; Gharib M; Rahmani M; Fiuji H; Jazayeri MH; Moetamani-Ahmadi M; Ferns GA; Avan A
    Pharmacogenomics; 2018 Apr; 19(5):463-474. PubMed ID: 29629612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.
    Pasmant E; Sabbagh A; Vidaud M; Bièche I
    FASEB J; 2011 Feb; 25(2):444-8. PubMed ID: 20956613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
    Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
    Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
    Chi JS; Li JZ; Jia JJ; Zhang T; Liu XM; Yi L
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):816-822. PubMed ID: 29270737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.